arrow_back Back to App

Request for Documents on Medicare Drug Price Negotiations

This document is a formal request from the House of Representatives to the Secretary of Health and Human Services for documents related to the negotiation of prescription drug prices under the Medicare program. This aims to increase transparency in drug pricing, which could indirectly affect the availability and costs of medications for citizens using this program.
Key points
The House of Representatives demands all documents from the Secretary of Health and Human Services related to Medicare drug price negotiations.
Requested documents include communications on the impact of excise taxes on drug manufacturers and potential loss of future drug development.
The goal is to obtain information on internal and external White House discussions regarding drug pricing and its consequences.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HRES_1284
Sponsor: Rep. McMorris Rodgers, Cathy [R-WA-5]
Process start date: 2022-07-26
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Of inquiry directing the Secretary of Health and Human Services to provide certain documentation to the House of Representatives relating to the negotiation of prices for prescription drugs under the Medicare prescription drug program.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HRES_1284.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-07-26.

What are the main provisions?

Key points include:

  • The House of Representatives demands all documents from the Secretary of Health and Human Services related to Medicare drug price negotiations.
  • Requested documents include communications on the impact of excise taxes on drug manufacturers and potential loss of future drug development.
  • The goal is to obtain information on internal and external White House discussions regarding drug pricing and its consequences.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. McMorris Rodgers, Cathy [R-WA-5].

What is the latest detailed status?

The latest detailed status is: Placed on the House Calendar, Calendar No. 140.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health